International Isotopes Inc. (INIS)

Market Cap	16.99M
Revenue (ttm)	11.46M
Net Income (ttm)	-2.32M
Shares Out	514.89M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37,150
Open	0.0621
Previous Close	0.0680
Day's Range	0.0621 - 0.0680
52-Week Range	0.0300 - 0.0900
Beta	0.50
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 3, 2023

About INIS

International Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services in the United States and internationally. It operates through five segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Radiological Services, and Fluorine Products. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imag...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Aug 14, 1997
• Employees: 32
• Stock Exchange: OTCMKTS
• Ticker Symbol: INIS

Financial Performance

In 2022, INIS's revenue was $11.18 million, an increase of 15.73% compared to the previous year's $9.66 million. Losses were -$310,705, -81.66% less than in 2021.